The Deal
Sunday, November 8, 
8:51 am

Dow Chemical wins approval, loses lifeline

  Share     E-Mail    Discussion    Print Story
chemicals.jpgClearing an antitrust hurdle is usually good news for a company with a pending acquisition. But Dow Chemical Co. might be excused for having mixed feelings about the European Commission's decision to approve its $18 billion purchase of Rohm and Haas Co.

Continue reading below

Also on Dealscape

With the approval, Dow and Rohm only need backing from the U.S. Federal Trade Commission to close the deal, with that determination expected any day now. If the merger is not completed by Jan. 10, Dow will be forced to pay a "ticking fee" of $100 million per month to compensate Rohm shareholders for any delay.

But a lot has changed for Dow since the Rohm deal was announced, including most notably a Kuwaiti partner's last-minute decision to back out of a joint venture with the company's plastics' unit. Dow had hoped to use at least $7 billion from that joint venture to pay for the Rohm deal, leaving it scrambling for cash as the deadline approaches.

Dow is now trying to juggle a desire not to overleverage its balance sheet with a tight merger agreement that appears to give Rohm considerable leeway to sue should the acquirer back out.

Which is where regulators could help out. Should the deal not win antitrust approval, Dow according to the agreement could walk away simply by paying a $750 million breakup fee. With the European ruling on Thursday, one chance Dow had as a lifeline has disappeared.

Analysts do not expect the FTC to stand in the way either, and for the record Dow has given no indication that it would like to walk away from Rohm. But the company, already short on options, lost one on Thursday. And that hardly seems cause for celebration. - Lou Whiteman

See Dow's release
See TheDeal.com story on Dow's troubles with Kuwait




Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Dealing with frozen bank lending

If your bank is not willing to lend, what can you do as your company continues to seek growth?


Judgment Call

The coming age of the renminbi

The Chinese currency will play an increasingly important role in international commerce and finance.


Industry Insight

Banking on PE investments

Howls of protest greeted the FDIC policy statement, but the financial services industry should get over it.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.